The European Medicines Agency’s Pharmacovigilance Risk Committee (PRAC) has agreed on a direct healthcare professional communication (DHPC) to remind healthcare professionals that extreme caution ...
AstraZeneca on Thursday touted Phase III data regarding its investigational inhibitor gefurulimab meeting its primary ...
South Korea-based Celltrion today announced that the US Food and Drug Administration (FDA) has designated Stoboclo (denosumab-bmwo) and Osenvelt (denosumab-bmwo) as interchangeable biosimilars to the ...
US anti-virals giant Gilead Sciences late yesterday announced its third quarter 2025 results of operations, reporting total ...
King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...
An Austrian biotech company developing protein-conjugation technologies aimed at accelerating vaccine and therapeutic ...
US biotech 4D Molecular Therapeutics (Nasdaq: FDMT) has granted Japan’s Otsuka Pharmaceutical (TYO: 4578) exclusive rights to ...
German family-owned pharma major Boehringer Ingelheim has licensed a pre-clinical program from Japan’s Kyowa Kirin to develop ...
The top 20 global biopharmaceutical companies saw their combined market capitalization rise 4% in the third quarter of 2025 ...
The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...
China’s R&D and manufacturing services provider WuXi AppTec has reached agreement for Hillhouse Investment Management to ...
Swiss pharma major Roche (ROG: SIX) has entered a global exclusive licensing agreement with China’s Qyuns Therapeutics for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback